Primary Testicular Lymphoma: A Study of 11 Cases
H. Regaieg, N. Ben Sayed, Y. Ben Youssef, B. Achour, S. Hmissa, H. El Omri, A. Khelif
International Blood Research & Reviews · pp. 213–221 · Published 4 Jun 2014
10.9734/IBRR/2014/10504Abstract
Primary testicular lymphoma (PTL) is an uncommon extranodal presentation constituting 1% of all NHL and 5% of all testicular neoplasm. The objective of our study was to identify the presenting signs and symptoms, treatment and outcome of patients with testicular lymphoma diagnosed at the Hematology department of Farhat Hached University Hospital from 1997 to 2007 and to perform bibliography review about this pathology. Eleven cases were identified; the median age was 61 years (range:31-83). All patients presented with testicular and scrotal swelling or mass. B symptoms (recurrent fever of>38ºC temperature, night sweets and unexplained weight loss of>10% of the body weight within six months prior to diagnosis) were present in 6 patients. According to the "Ann-Arbor staging system", 7 patients were classified stage IE( involving a single lymph node region (I) or single extralymphatic organ or site) and IIE (two or more involved lymph node regions on the same side of the diaphragm (II) or localized involvement of an extralymphatic organ or site), 4 patients were classified stage IVE (the presence of diffuse or disseminated involvement of one or more extralymphatic organs (e.g., liver, bone, marrow, lung), with or without associated lymph node involvement). International Prognostic index was low (<2) in 7 patients and high (≥2) in 4 cases. Orchidectomy was performed in all cases. Eight patients received chemotherapy based on COP (2cases), mini CEOP (3 cases), ACVBP (2 cases). Eight patients received central nervous system prophylaxis in the form of intrathecal methotrexate. Radiation at the dose of 40Gy was given to 3 patients. Three patients achieved complete remission. Two patients relapsed. The median survival was 3 months (range: 1 week-107 months). Testicular lymphoma is a rare and deadly form of extra nodal lymphoma, randomized prospective treatment trials may help to establish better treatment strategies.
References (14)
- 1 Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group [DOI]
- 2 Non-Hodgkin's lymphoma [DOI]
- 3 Primary testicular lymphoma [DOI]
- 4 Testicular lymphoma is associated with a high incidence of extranodal recurrence [DOI]
- 5 Primary Testicular Diffuse Large B-Cell Lymphoma: A Population-Based Study on the Incidence, Natural History, and Survival Comparison With Primary Nodal Counterpart Before and After the Introduction of Rituximab [DOI]
- 6 Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases [DOI]
- 7 Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. [DOI]
- 8 Testicular lymphoma A Retrospective, Population-based, Clinical and Immunohistochemical Study [DOI]
- 9 Extranodal non-Hodgkin's lymphoma presenting in the testicle. A clinical and pathologic study of 24 cases [DOI]
- 10 Malignant lymphoma of the testis: a study of 12 cases [DOI]
- 11 Testicular lymphoma: improved outcome with early brief chemotherapy. [DOI]
- 12 Primary malignant lymphoma of the testis.
- 13 Primary testicular non-Hodgkin lymphoma: A single institution experience from India [DOI]
- 14 [Malignant testicular non-Hodgkin's lymphoma in a young subject].
Cited by 0
No indexed citations yet.
Related research
- Pattern of Hearing Impairment in a Tertiary Institution in Ado Ekiti, Nigeria — shares topic coverage
- Weight Gain as Tuberculosis Treatment Regimen Progresses in Patients Receiving Antituberculosis Therapy — shares topic coverage
- TREAT-B has Good Accuracy in Selecting HBV Infected Patients for Treatment in Sudan — shares topic coverage
- Botox Treatment: A Comprehensive Review — shares topic coverage
- Harnessing Artificial Intelligence in Healthcare Analytics: From Diagnosis to Treatment Optimization — shares topic coverage
Article metrics
Real usage data collected on this platform.
27
Page views
0
PDF downloads
14
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.